Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interleukin-2 for Primary Smear-Positive Pulmonary Tuberculosis
NCT04766307Phase 4Unknown
- Sponsor
- Beijing Chest Hospital
- Start
- Jul 2016
- Primary completion
- Dec 2021
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of aldesleukin in pulmonary tuberculosis (TB), sponsored by Beijing Chest Hospital. Status: unknown.
02
Drugs
aldesleukin
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT04766307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04766307.